A carregar...
Antibiotics Approved for Marketing in Populations Specifically Excluded From Premarketing Trials, 1999–2018
Approval by the US Food and Drug Administration (FDA) of a drug for a given indication is thought to reassure clinicians, other health care providers, and patients that substantial evidence of effectiveness exists for specific indicated populations (patients and diseases). This study examines whethe...
Na minha lista:
| Publicado no: | Mayo Clin Proc |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8080959/ https://ncbi.nlm.nih.gov/pubmed/33276841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2020.07.023 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|